Drug Profile
Research programme: wound healing agents - Chemokine
Alternative Names: CTC-0422; CTCE 0422Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Chemokine Therapeutics
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Wounds
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Wounds in Canada
- 24 Jul 2007 CTCE 0422 is still in preclinical development for wound healing in Canada
- 07 Mar 2006 Preclinical trials in Wounds in Canada (unspecified route)